This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Fondazione Istituto Italiano Di Tecnologia, Charité – Universitätsmedizin Berlin, Fondazione Istituto Italiano Di Technologia. Active years: 2012-2022.
Company Filing History:
2 out of 147 
1 out of 283 
1 out of 24 Years Active: 2012-2022
Title: Guglielmo Lanzani: Innovator in Photonic Technologies
Introduction
Guglielmo Lanzani is a prominent inventor based in Milan, Italy. He has made significant contributions to the field of photonic technologies, particularly in the development of compounds and devices that have medical applications. With a total of 3 patents, his work focuses on innovative solutions for eye disorders and the inhibition of electrical activity in excitable cells.
Latest Patents
Lanzani's latest patents include groundbreaking inventions such as photochromic compounds for use in the treatment of eye disorders. These compounds feature a specific formula where Y and Z can be O, N, or P, and R can be various substituents, including C-Calkyl or heteroatoms like O, N, and S. The compositions derived from these compounds have significant medical uses. Another notable patent is for organic devices designed for the photoinhibition of excitable cells. These devices utilize a substrate and a photoreactive film made of non-conducting material, which, upon exposure to light, can inhibit the electrical activity of excitable cells.
Career Highlights
Throughout his career, Lanzani has worked with esteemed organizations such as the Fondazione Istituto Italiano Di Tecnologia and Charité – Universitätsmedizin Berlin. His research and innovations have positioned him as a key figure in the advancement of photonic technologies.
Collaborations
Lanzani has collaborated with notable colleagues, including Fabio Benfenati and Letizia Colella. Their joint efforts have contributed to the success of various projects and innovations in the field.
Conclusion
Guglielmo Lanzani's work exemplifies the intersection of innovation and medical technology. His patents and collaborations highlight his commitment to advancing the field of photonics for therapeutic applications.